Japan’s innovative pharma market has been on an upwards trajectory these last 12 months – despite what you may have seen in IQVIA thought leadership reports, in 27 December 2023
Suzhou, China-based cancer company CStone Pharmaceuticals has inked a deal with French drugmaker Servier to sell certain rights to Tibsovo (ivosidenib). 21 December 2023
Antibody specialist Nona Biosciences, a wholly-owned subsidiary of Hong Kong-based HBM Holdings, has entered into an exclusive license agreement with Pfizer. 15 December 2023